Real-World Insights - Trust - Expectations
We are delighted to invite you to the first Shimadzu Global Clinical Summit.
The Summit will bring together customers, clinical experts, global key opinion leaders and Shimadzu representatives from around the world. It is designed as an international platform for sharing real-world clinical insights, strengthening collaboration and discussing the future direction of clinical mass spectrometry. The Shimadzu Global Clinical Summit 2026 will take place at the nhow Roma Vittorio Veneto in Rome, Italy.
At the centre of the Summit will be the experiences of customers who use Shimadzu LC/MS systems in their daily clinical practice. Their perspectives will provide valuable insights into the practical application of Shimadzu solutions in clinical laboratories and the evolving role of mass spectrometry in clinical practice.
Approximately 150 participants are expected to attend, with a strong focus on customer participation. Mr Yamamoto, CEO of Shimadzu Corporation, will attend, making this summit an especially meaningful occasion.
Through scientific presentations, discussions and practical insights, the Summit will highlight:
The reliability and proven performance of Shimadzu clinical solutions
The future potential and scalability of clinical mass spectrometry
The value of trusted collaboration between laboratories, experts and Shimadzu
Shimadzu’s continued role as a trusted partner in clinical mass spectrometry
Clinical Focus Areas
The scientific programme will cover four key areas of clinical mass spectrometry:
Therapeutic Drug Monitoring
Endocrinology
Newborn Screening
Toxicology
Participants can look forward to presentations by global key opinion leaders and customers, expert panel discussions, scientific poster sessions and opportunities for international networking and knowledge exchange.
Program Speakers
Meet the experts and clinical leaders contributing to the Shimadzu Global Clinical Summit 2026.
Monday, 7 December 2026
7 December 2026 Therapeutic Drug Monitoring
Dr. Christina Trambas
Medical Director
St Vincent’s Hospital Melbourne
Australia
Presentation title The Best of Both Worlds: Routine Integration of Mass Spectrometry into the Clinical Diagnostic Laboratory While Preserving Laboratory Autonomy
View full speaker details
Biography
Christina Trambas is a Chemical Pathologist, clinician-scientist, and the Medical Director of St Vincent’s Pathology, Melbourne. She studied Medicine at the University of Melbourne and is a Fellow of the Royal College of Pathologists of Australasia and the Australasian Association for Clinical Biochemistry and Laboratory Medicine.
Prior to entering Medicine, Christina completed a Bachelor of Science with Honours and a PhD in Immunology at The University of Tasmania and undertook a post-doctoral fellowship at The Dunn School of Pathology at Oxford University.
Abstract
Mass spectrometry offers the clinical diagnostic laboratory exceptional sensitivity and selectivity. However, its routine use has been limited by complexity and high resource requirements.
This presentation discusses an integration model that combines automated sample processing, track automation and interfacing while preserving a laboratory’s flexibility and autonomy. The approach can support the rapid implementation of mass spectrometry assays, including laboratory-developed tests.
Focus areas
Key topics: CLAM/LCMS, Abbott, Corelab
LinkedIn
LinkedIn
Additional profile
Professional profile
7 December 2026 Therapeutic Drug Monitoring
Dr. Frank Streit
Professional title: Coming soon
Institute of Clinical Chemistry / UMG-Laboratories
University Medical Center Göttingen
Germany
Presentation title Coming soon
View full speaker details
Biography
Dr. Frank Streit established LC-MS/MS methods for the quantification of immunosuppressants in the mass spectrometry laboratory at the University of Göttingen. He started routine quantification of sirolimus and everolimus in 1999 and of tacrolimus and ciclosporin in 2004.
Abstract
Coming soon
Focus areas
Key topics: CLAM/LCMS, Corelab, EU-IC
LinkedIn
Coming soon
7 December 2026 Therapeutic Drug Monitoring
Prof. William Clarke
Professor of Pathology
Johns Hopkins School of Medicine
United States
Presentation title Coming soon
View full speaker details
Biography
Dr. Clarke received his PhD in Analytical Chemistry from the University of Nebraska in Lincoln in 2000, followed by a post-doctoral fellowship in Clinical Chemistry at the Johns Hopkins School of Medicine.
He also received an MBA focused on medical services management from the Carey School of Business at Johns Hopkins. He is a Professor in the Department of Pathology at Johns Hopkins.
Abstract
Coming soon
Focus areas
Key topics: CLAM/LCMS, LDT, Corelab, COBAS
LinkedIn
Coming soon
Additional profile
Professional profile
7 December 2026 Toxicology
Prof. Franck Saint-Marcoux
Head of the Clinical Laboratory
Department of Pharmacology and Toxicology
Limoges University Hospital
France
Presentation title Supercritical Fluid Chromatography Coupled to High-Resolution Mass Spectrometry: Applications in Forensic Toxicology
View full speaker details
Biography
Professor Franck Saint-Marcoux is Head of the Clinical Laboratory at Limoges University Hospital, where he also leads the Forensic Toxicology Unit. He is Professor of Toxicology at the University of Limoges and has broad expertise in forensic, clinical and environmental toxicology.
Abstract
Coming soon
Focus areas
Key topics: Toxicology, EU-IC
LinkedIn
LinkedIn
7 December 2026 Newborn Screening
Prof. Giancarlo La Marca
Director of Newborn Screening
University of Florence and Meyer Children’s Hospital IRCCS
Italy
Presentation title Newborn Screening for Lysosomal Storage Disorders: The Combination of 1st and 2nd Tier Test
View full speaker details
Biography
Prof. Giancarlo La Marca is Full Professor of Clinical Biochemistry and Clinical Molecular Biology at the University of Florence, President of the Mass Spectrometry Centre, and Director of Newborn Screening at Meyer Children’s Hospital IRCCS.
He is an internationally recognized leader in newborn screening and clinical mass spectrometry and has authored more than 220 peer-reviewed publications.
Abstract
Coming soon
Focus areas
Key topics: NBS, GAG, EU-IC
LinkedIn
Coming soon
Additional profile
Professional profile
Tuesday, 8 December 2026
8 December 2026 Endocrinology
Dr. Nigel Clarke
Professional title: Coming soon
Quest Diagnostics
United States
Presentation title Coming soon
View full speaker details
Biography
Dr. Nigel Clarke received his PhD in mass spectrometry and analytical chemistry from the University of Kent at Canterbury in England. He completed postdoctoral fellowship training in biomedical mass spectrometry at the Mayo Clinic in Rochester, Minnesota.
Abstract
Coming soon
Focus areas
Key topics: Steroids, QX, Quest R&D
LinkedIn
LinkedIn
8 December 2026 Endocrinology
Mr. Tony Pereira
Technical Manager, Mass Spectrometry Platform
Department of General Biochemistry
Rouen University Hospital
France
Presentation title Automated LC-MS/MS Bioanalysis Platform: From Method Implementation to Long-Term Clinical Perspectives
View full speaker details
Biography
Tony Pereira is a Hospital Engineer and Technical Manager of the Clinical Mass Spectrometry Core Facility at the Institute of Clinical Biology of Rouen University Hospital. With 28 years of experience, his work focuses on the development and validation of chromatographic methods coupled with mass spectrometry applied to laboratory medicine.
Abstract
Coming soon
Focus areas
Key topics: Steroids, CLAM/LCMS, EU-IC
LinkedIn
Coming soon
8 December 2026 Endocrinology
Dr. Daryl Hee
Senior Assistant Director and Clinical Scientist
Changi General Hospital
Singapore
Presentation title From Method to Medicine: Translating LC-MS/MS LDTs into Routine Clinical Service
View full speaker details
Biography
Dr. Daryl Hee is a Senior Assistant Director and Clinical Scientist at Changi General Hospital, Singapore, where he heads the Shimadzu-CGH Clinomics Centre. He is also a Clinical Assistant Professor at Duke-NUS Medical School.
Abstract
Coming soon
Focus areas
Key topics: Steroids
LinkedIn
Coming soon
8 December 2026 Category: Coming soon
Dr. Ramesh Kinah
Chief Operating Officer (COO)
Thyrocare Technologies
India
Presentation title Coming soon
View full speaker details
Biography
Coming soon
Abstract
Coming soon
Focus areas
Key topics: Private testing laboratory, Vitamin D, Steroids
LinkedIn
Coming soon
Preliminary Schedule
Monday, 7 December 2026
10:30 am Opening of the Shimadzu Global Clinical Summit
Scientific presentations, customer insights, panel discussions and networking sessions will follow throughout the day.
19:00 pm Gala dinner - Tuesday, 8 December 2026
The scientific programme will continue with presentations, discussions and poster sessions.
15:00 pm Closing of the Clinical Summit
15:30 – 18:30 pm Sightseeing and networking programme in Rome
Join us in Rome
We would be delighted to welcome you as one of our invited guests, as your expertise and perspective would make a valuable contribution to this important event and to the exchange within our global clinical community.
Rome, Italy
nHow Roma Vittorio Veneto
